This facility will span across 2.200m2 with multiple ISO7 clean rooms intended for the manufacturing of silicone tubing, thermoplastic tubing, bioprocessing bags and the integration of single use fluid transfer systems.

Venair Group, globally known for its biopharmaceutical tubing and its custom shaped hoses for a variety of markets, announces is the planned expansion of its facilities. Recent demand and growth from the biopharmaceutical market, particularly in support of requirements pertaining to the global production of COVID-19 vaccines, has resulted in expansion plans to increase Venair Biotech division manufacturing capacity.  

This new facility will be located in Terrassa Spain, a city 20km north west of Barcelona and will be integrated into the campus along with the current production centers owned by the group and the headquarters. It is expected to be completed and production ready by Q4 2022.

Today the company makes use of cleanrooms for production of Venair Biotech products and solutions: in Barcelona, and in Ho Chi Minh, Vietnam, and employs a total of 350 people. The global demand of single use solutions for biotechnological applications stressed the supply chain of the industry and therefore has accelerated Venair’s execution timeline for this project as well as other Venair investments in infrastructure, capacity and product development.

Once operational, the excellence center will double the current production capacity for Venair Biotech products and solutions and will employ approximately 100 team members between highly qualified operators, engineers and scientists.

For more information please contact:

Marina Romero
Marketing Department
T (+34) 93 736 4860
marketing@venair.com

Nasim A. Moucharrafie
Biotech Division Manager
T (+34) 93 736 4860
biotech@venair.com